Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126020072 | 12602007 | 2 | F | 20160726 | 20160728 | 20160801 | PER | US-PFIZER INC-2016327079 | PFIZER | 56.00 | YR | F | Y | 104.00000 | KG | 20160801 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126020072 | 12602007 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | 40 MG, 3X/DAY (2 TABS TID) | 21845 | 40 | MG | FILM-COATED TABLET | TID | |||||||
126020072 | 12602007 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 3 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 4 | C | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | 200 MG, 1X/DAY | 0 | 200 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | TABLET | BID | |||||||
126020072 | 12602007 | 6 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | 12 IU, 1X/DAY (100UNIT/ML) | 0 | 12 | IU | SOLUTION FOR INJECTION | QD | |||||||
126020072 | 12602007 | 8 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 50 MG, 1X/DAY (10 MG TABLET- 5 TABLET IN THE MORNING ONCE A DAY) | 0 | 50 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 300 UG, 1X/DAY | 0 | 300 | UG | TABLET | QD | |||||||
126020072 | 12602007 | 10 | C | DIGOXIN. | DIGOXIN | 1 | 125 UG, 1X/DAY | 0 | 125 | UG | TABLET | QD | |||||||
126020072 | 12602007 | 11 | C | TORSEMIDE. | TORSEMIDE | 1 | 40 MG, 2X/DAY (20 MG TABLET 2 TABLET TWICE A DAY) | 0 | 40 | MG | TABLET | BID | |||||||
126020072 | 12602007 | 12 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 50 MG, UNK (1 TABLET ONCE A DAY NOT-TAKING/PRN) | 0 | 50 | MG | TABLET | QD | |||||||
126020072 | 12602007 | 13 | C | LORATADINE. | LORATADINE | 1 | 10 MG, AS NEEDED (ONCE A DAY PRN) | 0 | 10 | MG | TABLET |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126020072 | 12602007 | Drug ineffective | |
126020072 | 12602007 | Erythema | |
126020072 | 12602007 | Fluid retention | |
126020072 | 12602007 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |